Okhla, Delhi
- GST NO. : 07ABEFM6994Q2Z7
Twitter| Business Type | Exporter, Supplier |
| Form | Tablets |
| Dosage | As per Doctor's Prescription |
| Treatment | Cancer |
| Click to view more | |
Preferred Buyer From
| Location | Worldwide |
Product Details
Storage
Cool and Dry Place
Best Before
36 Months from Manufacturing
Are you looking for or in search of FDA approved “Letrozole tablets in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for Breast cancer treatment. Need Access of “Letrozole tablets, get in touch with our healthcare professional.
Femara is an aromatase inhibitor indicated for:
- Adjuva nt treatment of postmenopausal women with hormone receptor positive early brea st cancer
- Extended adjuvant treatment of postmenopausal women with early brea st cancer who have received prior standard adju vant ta moxifen thera py
- First a nd second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer
DOSAGE AND ADMINISTRATION
- Femara tablets are taken orally without regard to meals
- Recommended dose: 2.5.mg once daily
Looking for "Letrozole Tablets" ?
Explore More Products
